Paul Peter Tak, Chief Executive Officer at Candel Therapeutics, Inc. (CADL), bought 15,985 shares at $1.92 ($30K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.70 | 3,050 | $5K | 17.3% |
| 2 | $1.92 | 12,935 | $25K | 82.7% |
| Total | $1.88 avg | 15,985 | $30K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $314K | — | Filing → |
| CADL | SELL | 2025-01-10 | $348K | — | Filing → |
| CADL | SELL | 2024-12-03 | $445K | — | Filing → |